respiratory
virus
vaccines
ii
mycoplasma
pneumoniae
eaton
agent
vaccines
purified
concentrated
formalinkilled
vaccines
prepared
m
pneumoniae
propagated
serumfree
artificial
medium
vaccines
aqueous
incorporated
alum
emulsified
peanut
oil
adjuvant
adjuvant
two
different
concentrations
mycoplasma
included
preparation
serum
neutralizing
cf
antibody
responses
measured
hamsters
monkeys
institutionalized
persons
following
sometimes
vaccinations
preparations
highly
antigenic
animals
man
alum
vaccines
better
aqueous
vaccines
adjuvant
appeared
give
best
results
although
bleeding
times
always
optimal
demonstrating
maximal
effect
persons
without
detectable
antibody
initially
thus
would
vulnerable
infection
gave
better
responses
vaccine
preexisting
antibody
alum
vaccine
acceptable
formulation
use
man
doses
vaccine
necessary
induce
neutralizing
antibody
persons
initially
without
detectable
antibody
local
systemic
reaction
clinical
consequence
noted
persons
vaccinated
recent
unpublished
findings
indicate
a
high
degree
effectiveness
alum
vaccine
stimulating
antibody
preschool
children
protecting
children
adults
natural
disease
mentioned
